Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
cCTL-GL01 in Advanced Gastrointestinal Tumors
NCT07735065Phase 1Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Aug 2026
- Primary completion
- Aug 2028
01
Overview
Phase 1, open-label, single-arm trial in gastrointestinal cancer, sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Dose-Limiting Toxicities at 16 weeks. Planned start Aug 2026; status: not yet recruiting.
02
Conditions
gastrointestinal cancer
Beyond the preview
Go deeper on NCT07735065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07735065.